Vivani Medical VANI Neuromodulation Division — Operating Lease Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vivani Medical in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseExpense.
The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vivani Medical's neuromodulation division — operating lease expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vivani Medical's neuromodulation division — operating lease expense?
- Vivani Medical (VANI) reported neuromodulation division — operating lease expense of $30K in Q1 2026.
- How has Vivani Medical's neuromodulation division — operating lease expense changed year-over-year?
- Vivani Medical's neuromodulation division — operating lease expense decreased by 72.7% year-over-year, from $110K to $30K.
- What does neuromodulation division — operating lease expense mean?
- This metric represents the periodic costs associated with leasing facilities, equipment, or other assets utilized specifically by the Neuromodulation Division. It reflects the fixed operational overhead required to maintain the physical footprint necessary for the division's activities. Analyzing this helps investors understand the division's long-term contractual commitments and fixed cost obligations.